Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
metCYP study of CYP2D6 phenotyping in tamoxifen-treated localized and metastatic breast cancer
NL-OMON39759Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tamoxifen and dextromethorphan in breast cancer (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Delta over baseline values over 0 to 120 minutes, Area under the DOB curve from 0 to 120 minutes and 2 more. Started Feb 2013; status: active, not recruiting.
02
Drugs
tamoxifendextromethorphan
03
Conditions
breast cancer
Beyond the preview
Go deeper on NL-OMON39759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39759.